|
|
||||||||
Clinical Investigation |
1 Department of Otolaryngology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea; 2 Department of Nuclear Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea; 3 Department of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea; and 4 Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea
Correspondence: For correspondence contact: Jong-Lyel Roh, MD, PhD, Department of Otolaryngology, Asan Medical Center, University of Ulsan College of Medicine, 388-1, Pungnap-dong, Songpa-gu, Seoul 138-736, South Korea. E-mail: rohjl{at}amc.seoul.kr
The clinical utility of 18F-FDG PET in evaluating salivary gland malignancies has not been well defined. We therefore evaluated the utility of 18F-FDG PET in management for patients with salivary gland cancers. Methods: Thirty-four patients with newly diagnosed salivary gland cancers underwent CT and 18F-FDG PET before surgical resection with radiotherapy. The diagnostic accuracies of CT and 18F-FDG PET for detecting primary tumors and neck metastases were compared with a histopathologic reference. We determined the relationship between the maximum standardized uptake value (SUV) of the tumor and clinicopathologic parameters such as sex, age, local tumor invasion, T and N categories, TNM stage, and histologic grade, as well as their associations with disease-free survival (DFS). Results: 18F-FDG PET was more sensitive than CT for the detection of primary tumors (91.2% vs. 79.4%; P < 0.05), cervical metastases (80.5% vs. 56.1%; P < 0.05), and distant metastases in 2 patients at initial staging. High-grade malignancies had higher mean maximum SUVs than did low- and intermediate-grade malignancies (4.6 vs. 2.8; P = 0.011). T and N categories were independent determinants of DFS (P < 0.05), but the maximum SUV (4.0) was not. During a mean follow-up of 25.1 mo, 18F-FDG PET correctly diagnosed localregional recurrences in 6 patients and new distant metastases in 9 patients. Conclusion: Our findings indicate that, in patients with salivary gland malignancies, 18F-FDG PET is clinically useful in initial staging, histologic grading, and monitoring after treatment but not in predicting patient survival.
Key Words: salivary gland cancer 18F-FDG PET staging histologic grading predictive factor standardized uptake value
COPYRIGHT © 2007 by the Society of Nuclear Medicine, Inc.
Related articles in JNM:
This article has been cited by other articles:
![]() |
S. Y. Jeong, K. S. Lee, J. Han, B.-T. Kim, T. S. Kim, Y. M. Shim, and J. Kim Integrated PET/CT of Salivary Gland Type Carcinoma of the Lung in 12 Patients Am. J. Roentgenol., December 1, 2007; 189(6): 1407 - 1413. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-S. Jeong, M. K. Chung, Y.-I. Son, J. Y. Choi, H. J. Kim, Y. H. Ko, and C.-H. Baek Role of 18F-FDG PET/CT in Management of High-Grade Salivary Gland Malignancies J. Nucl. Med., August 1, 2007; 48(8): 1237 - 1244. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |